loading
Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose
Schlusskurs vom Vortag:
$4.26
Offen:
$4.24
24-Stunden-Volumen:
416.37K
Relative Volume:
0.28
Marktkapitalisierung:
$419.69M
Einnahmen:
$58.36M
Nettoeinkommen (Verlust:
$-25.72M
KGV:
-11.60
EPS:
-0.3641
Netto-Cashflow:
$-24.91M
1W Leistung:
-3.32%
1M Leistung:
+31.62%
6M Leistung:
+36.73%
1J Leistung:
+25.37%
1-Tages-Spanne:
Value
$4.1809
$4.29
1-Wochen-Bereich:
Value
$3.955
$4.50
52-Wochen-Spanne:
Value
$2.12
$5.80

Aquestive Therapeutics Inc Stock (AQST) Company Profile

Name
Firmenname
Aquestive Therapeutics Inc
Name
Sektor
Healthcare (1168)
Name
Branche
Drug Manufacturers - Specialty & Generic (83)
Name
Telefon
908-941-1900
Name
Adresse
30 TECHNOLOGY DRIVE, WARREN, NJ
Name
Mitarbeiter
142
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-05
Name
Neueste SEC-Einreichungen
Name
AQST's Discussions on Twitter

Vergleichen Sie AQST mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
AQST
Aquestive Therapeutics Inc
 4.2253 394.33M 58.36M -25.72M -24.91M -0.3641
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
 153.02 67.31B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
 14.65 45.95B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
 9.825 43.35B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
 16.44 18.68B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
 303.09 13.44B 2.99B 1.21B 1.13B 25.06

Aquestive Therapeutics Inc Stock (AQST) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-06-02 Fortgesetzt Oppenheimer Outperform
2024-12-17 Eingeleitet Cantor Fitzgerald Overweight
2024-05-10 Eingeleitet Leerink Partners Outperform
2024-04-11 Eingeleitet Piper Sandler Overweight
2024-03-28 Eingeleitet Raymond James Outperform
2021-04-07 Fortgesetzt RBC Capital Mkts Outperform
2019-04-22 Eingeleitet H.C. Wainwright Buy
2019-01-03 Eingeleitet Lake Street Buy
2018-08-20 Eingeleitet JMP Securities Mkt Outperform
2018-08-20 Eingeleitet RBC Capital Mkts Outperform
Alle ansehen

Aquestive Therapeutics Inc Aktie (AQST) Neueste Nachrichten

pulisher
Jul 23, 2025

Is Aquestive Therapeutics Inc. a good long term investmentFree Real-Time Stock Data - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Aquestive Therapeutics Inc. Stock Analysis and ForecastFree Wealth Planning Blueprint - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

What drives Aquestive Therapeutics Inc. stock priceFree Capital Allocation Plans - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

What analysts say about Aquestive Therapeutics Inc. stockAccelerated profit realization - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Aquestive Therapeutics Names Sherry Korczynski as Chief Commercial Officer - GlobeNewswire

Jul 22, 2025
pulisher
Jul 22, 2025

EpiPen Veteran to Lead Aquestive's Revolutionary Oral Epinephrine Launch as New Chief Commercial Officer - Stock Titan

Jul 22, 2025
pulisher
Jul 21, 2025

After Leaping 29% Aquestive Therapeutics, Inc. (NASDAQ:AQST) Shares Are Not Flying Under The Radar - simplywall.st

Jul 21, 2025
pulisher
Jul 21, 2025

Aquestive's Anaphylm to be reviewed by Health Canada - MSN

Jul 21, 2025
pulisher
Jul 18, 2025

When is the best time to buy Aquestive Therapeutics Inc. stockAlpha Stock Ideas - Newser

Jul 18, 2025
pulisher
Jul 18, 2025

Will Aquestive Therapeutics Inc. stock benefit from AI tech trendsFree Professional Portfolio Management - Newser

Jul 18, 2025
pulisher
Jul 17, 2025

Why Aquestive Therapeutics Inc. stock attracts strong analyst attentionSteady Income Ideas - beatles.ru

Jul 17, 2025
pulisher
Jul 16, 2025

Cantor Equity Partners I, Inc. shares rise 2.24% premarket after Aquestive Therapeutics' positive drug submission meeting with Health Canada. - AInvest

Jul 16, 2025
pulisher
Jul 16, 2025

11,303 Shares in Aquestive Therapeutics, Inc. (NASDAQ:AQST) Acquired by Cambridge Investment Research Advisors Inc. - Defense World

Jul 16, 2025
pulisher
Jul 15, 2025

Aquestive Therapeutics Provides International Expansion Update for Anaphylm™ (epinephrine) Sublingual Film - GlobeNewswire

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Aquestive Therapeutics Inc. stock price move sharplyFree High-Profit Stock Picks - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Aquestive's Anaphylm to be reviewed by Health Canada (AQST) - Seeking Alpha

Jul 15, 2025
pulisher
Jul 15, 2025

Aquestive schedules regulatory meetings for epinephrine film in Canada, EU - Investing.com Canada

Jul 15, 2025
pulisher
Jul 15, 2025

How Aquestive Therapeutics Inc. stock performs during market volatilityDaily Stock Radar - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Aquestive Therapeutics Says Canadian Regulator Has Granted Meeting to Discuss Anaphylm Approval - MarketScreener

Jul 15, 2025
pulisher
Jul 15, 2025

Aquestive schedules regulatory meetings for epinephrine film in Canada, EU By Investing.com - Investing.com Nigeria

Jul 15, 2025

Finanzdaten der Aquestive Therapeutics Inc-Aktie (AQST)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Ähnlich wie AQST

drug_manufacturers_specialty_generic LNTH
$70.71
price down icon 3.78%
drug_manufacturers_specialty_generic ELAN
$14.78
price down icon 1.53%
drug_manufacturers_specialty_generic VTRS
$9.315
price down icon 0.59%
drug_manufacturers_specialty_generic RDY
$14.77
price up icon 1.10%
drug_manufacturers_specialty_generic NBIX
$132.49
price down icon 0.87%
drug_manufacturers_specialty_generic UTHR
$304.68
price down icon 0.33%
In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters
Kapitalisierung:     |  Volumen (24h):